PIER 88 INVESTMENT PARTNERS LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1697366
SAN FRANCISCO, CA
Position in HALO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$665,295
-$562,675 QoQ
Shares Held
8,500
-55.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#353
of 661 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PIER 88 INVESTMENT PARTNERS LLC holds $6,341,408 across 13 Biotechnology names. HALO ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
2,400 | $892,008 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
2,600 | $821,834 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,300 | $698,035 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
8,500 | $665,295 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
79,900 | $627,215 | |
| 6 | ABSI |
Absci Corp
|
42,500 | $492,575 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,300 | $469,224 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,100 | $356,495 |
All Filings in HALO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $665,295 | 8,500 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,227,970 | 19,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,297,544 | 19,280 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,471,200 | 20,060 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $547,250 | 10,520 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $507,289 | 7,950 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||